Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$3.91 - $7.31 $877,920 - $1.64 Million
-224,532 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.27 - $9.48 $734,219 - $2.13 Million
224,532 New
224,532 $1.19 Million
Q3 2020

Nov 16, 2020

SELL
$7.71 - $10.79 $385,500 - $539,500
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$9.0 - $13.12 $450,000 - $656,000
50,000 New
50,000 $450,000

Others Institutions Holding BIOR

About BIORA THERAPEUTICS, INC.


  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $114M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.